Find Oxprenolol manufacturers, exporters & distributors on PharmaCompass

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF, 1 NDC API

1 API Suppliers
1 USDMF
1 NDC API

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 4 FDA Orange Book, 1 Europe

5 FDF Dossiers
4 FDA Orange Book
1 Europe

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices

globalSalesInformation
1 Finished Drug Prices

REF. STANDARDS & IMPURITIES

1 USP , 1 Others

otherSolutions
1 USP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

4DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 6452-73-9, Trasicor, Oxprenolol hcl, Evinrozit, Ranidrox, Rixiprol

Molecular Formula

C₁₅H₂₄ClNO₃

Molecular Weight

301.81 g/mol

InChI Key

COAJXCLTPGGDAJ-UHFFFAOYSA-N

FDA UNII

F4XSI7SNIU

A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

1 2D Structure

Oxprenolol

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride

2.1.2 InChI

InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H

2.1.3 InChI Key

COAJXCLTPGGDAJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl

2.2 Other Identifiers

2.2.1 UNII

F4XSI7SNIU

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Coretal

2. Hydrochloride, Oxprenolol

3. Koretal

4. Oxprenolol

5. Slow Trasicor

6. Tevacor

7. Trasicor

8. Trasicor, Slow

2.3.2 Depositor-Supplied Synonyms

1. 6452-73-9

2. Trasicor

3. Oxprenolol Hcl

4. Evinrozit

5. Ranidrox

6. Rixiprol

7. Coretal

8. Oxprenolol.hcl

9. Ba-39089

10. Ciba 39089ba

11. F4xsi7sniu

12. Oxprenolol (hydrochloride)

13. 2-propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, Hydrochloride

14. Ba-39,089

15. 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol Hydrochloride

16. 1-(2-(allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol Hydrochloride

17. (+/-)-oxprenolol (hydrochloride)

18. 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride

19. Secondafil

20. Vrachor

21. Flecor

22. Slow-trasicor

23. Dsstox_cid_1093

24. (+/-)-ba 39089

25. Dsstox_rid_75936

26. Dsstox_gsid_21093

27. Oxiprenolol Hydrochloride

28. Dl-alprenolol Hydrochloride

29. Ccris 1097

30. Unii-f4xsi7sniu

31. C-39089-ba

32. Einecs 229-260-5

33. Einecs 245-358-0

34. Ba 39089

35. (+-)-ba 39089

36. Okuspurecol (tn)

37. Oxprenolol Hydrochloride [usan:usp:jan]

38. Dl-1-(2-allylphenoxy)-3-isopropylaminopropan-2-ol Hydrochloride

39. Ncgc00016675-01

40. 2-(o-allyloxyphenoxy)-2-hydroxy-n-isopropyl-1-propylamine Hydrochloride

41. 2-propanol, 1-(o-(allyloxy)phenoxy)-3-(isopropylamino)-, Hydrochloride, (+-)-

42. Cas-6452-73-9

43. 2-propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, Hydrochloride

44. 2-propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, Hydrochloride, (+-)-

45. Mls002154132

46. Schembl123517

47. Chembl1200745

48. Dtxsid5021093

49. Hms1571c16

50. Hy-b1486

51. Tox21_110556

52. Mfcd00058008

53. Oxprenolol Hydrochloride [mi]

54. Oxprenolol Hydrochloride (jp17/usp)

55. Oxprenolol Hydrochloride [jan]

56. (1)-(3-(2-(allyloxy)phenoxy)-2-hydroxypropyl)isopropylammonium Chloride

57. Akos015994696

58. Tox21_110556_1

59. Ccg-221057

60. Ks-1152

61. Oxprenolol Hydrochloride [usan]

62. 1-[(1-methylethyl)amino]-3-{[2-(prop-2-en-1-yloxy)phenyl]oxy}propan-2-ol Hydrochloride

63. Ncgc00179342-03

64. Oxprenolol Hydrochloride [usp-rs]

65. Oxprenolol Hydrochloride [who-dd]

66. 22972-97-0

67. Smr001233439

68. Db-054683

69. Cs-0013185

70. Ft-0630349

71. Sw219956-1

72. Oxprenolol Hydrochloride [ep Impurity]

73. Oxprenolol Hydrochloride [orange Book]

74. D01806

75. Oxprenolol Hydrochloride [usp Impurity]

76. Oxprenolol Hydrochloride [usp Monograph]

77. Sr-01000841263

78. Sr-01000841263-2

79. Q27277643

80. Oxprenolol Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)

81. 1-(2-(allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol Hcl

82. 1-(isopropylamino)-2-hydroxy-3-[o-(allyloxy)phenoxy]propane Hydrochloride

83. 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-2-propanol Hydrochloride

84. 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol Hydrochloride

85. 2-propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-, Hydrochloride (1:1)

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₁₅H₂₄ClNO₃
Molecular Weight	301.81 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	9
Exact Mass	301.1444713 g/mol
Monoisotopic Mass	301.1444713 g/mol
Topological Polar Surface Area	50.7 Å²
Heavy Atom Count	20
Formal Charge	0
Complexity	246
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Adrenergic beta-Antagonists

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)

Anti-Anxiety Agents

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

Sympatholytics

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)

API SUPPLIERS